These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 6330386)

  • 81. Thrombocytopenic purpura following varicella-zoster vaccination.
    Lee SY; Komp DM; Andiman W
    Am J Pediatr Hematol Oncol; 1986; 8(1):78-80. PubMed ID: 3013041
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Vaccination against varicella].
    Magdzik W
    Przegl Epidemiol; 1995; 49(3):321-4. PubMed ID: 7491430
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Long-term protective immunity of recipients of the OKA strain of live varicella vaccine.
    Asano Y; Nagai T; Miyata T; Yazaki T; Ito S; Yamanishi K; Takahashi M
    Pediatrics; 1985 Apr; 75(4):667-71. PubMed ID: 2984636
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1996 Jul; 45(RR-11):1-36. PubMed ID: 8668119
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Oka/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies.
    Kuter BJ; Weibel RE; Guess HA; Matthews H; Morton DH; Neff BJ; Provost PJ; Watson BA; Starr SE; Plotkin SA
    Vaccine; 1991 Sep; 9(9):643-7. PubMed ID: 1659052
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Application of a live attenuated varicella vaccine to hospitalized children and its protective effect on spread of varicella infection.
    Asano Y; Yazaki T; Miyata T; Nakayama H; Hirose S
    Biken J; 1975 Mar; 18(1):35-40. PubMed ID: 167708
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Experience and reason: twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine.
    Asano Y; Suga S; Yoshikawa T; Kobayashi I; Yazaki T; Shibata M; Tsuzuki K; Ito S
    Pediatrics; 1994 Oct; 94(4 Pt 1):524-6. PubMed ID: 7936864
    [No Abstract]   [Full Text] [Related]  

  • 88. Efficacy of postexposure immunization with live attenuated varicella vaccine in the household setting--a pilot study.
    Mor M; Harel L; Kahan E; Amir J
    Vaccine; 2004 Dec; 23(3):325-8. PubMed ID: 15530676
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [Development of live varicella vaccine].
    Takahashi M; Asano Y; Kamiya H; Baba K
    Nihon Rinsho; 1985 Jul; 43(7):1535-41. PubMed ID: 2997506
    [No Abstract]   [Full Text] [Related]  

  • 90. Varicella vaccine for immunocompromised children: results of collaborative studies in the United States and Canada.
    LaRussa P; Steinberg S; Gershon AA
    J Infect Dis; 1996 Nov; 174 Suppl 3():S320-3. PubMed ID: 8896539
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Effect and follow-up study on varicella vaccine.
    Katsushima N; Yazaki N; Sakamoto M
    Biken J; 1984 Sep; 27(2-3):51-8. PubMed ID: 6100058
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Immunogenicity of a two-dose regime of varicella vaccine in children with cancers.
    Leung TF; Li CK; Hung EC; Chan PK; Mo CW; Wong RP; Chik KW
    Eur J Haematol; 2004 May; 72(5):353-7. PubMed ID: 15059071
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Application of a live varicella vaccine to hospitalized children and its follow-up study.
    Katsushima N; Yazaki N; Sakamoto M; Fujiyama J; Nakagawa M; Okuyama Y; Takahashi M
    Biken J; 1982 Mar; 25(1):29-42. PubMed ID: 6289798
    [No Abstract]   [Full Text] [Related]  

  • 94. [Preliminary study of an attenuated varicella-zoster vaccine (Webster strain) in 27 children without immunologic disorders].
    Hediard B; Burguiere AM; Devillechabrolle A; Lemerle S; Reinert P; Plotkin SA; Huraux JM
    Ann Pediatr (Paris); 1983 Jun; 30(6):440-4. PubMed ID: 6309063
    [No Abstract]   [Full Text] [Related]  

  • 95. Live attenuated varicella vaccine: immunization of healthy children with the OKA strain.
    Arbeter AM; Starr SE; Weibel RE; Plotkin SA
    J Pediatr; 1982 Jun; 100(6):886-93. PubMed ID: 6283051
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Varicella vaccination: where do we go from here?
    Brunell PA
    Hosp Pract; 1980 Sep; 15(9):91-3, 97, 100-1 passim. PubMed ID: 6250972
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Letter: Live varicella vaccine.
    Lancet; 1975 Jan; 1(7898):98-9. PubMed ID: 46043
    [No Abstract]   [Full Text] [Related]  

  • 98. [Varicella zoster virus vaccine--a review].
    Petersen CS; Buhl MR; Heilmann CJ
    Ugeskr Laeger; 1997 Feb; 159(8):1081-5. PubMed ID: 9072851
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka/Merck varicella vaccine.
    Bernstein HH; Rothstein EP; Watson BM; Reisinger KS; Blatter MM; Wellman CO; Chartrand SA; Cho I; Ngai A; White CJ
    Pediatrics; 1993 Dec; 92(6):833-7. PubMed ID: 8233746
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Modified cases of chickenpox after varicella vaccination: correlation of protection with antibody response.
    White CJ; Kuter BJ; Ngai A; Hildebrand CS; Isganitis KL; Patterson CM; Capra A; Miller WJ; Krah DL; Provost PJ
    Pediatr Infect Dis J; 1992 Jan; 11(1):19-23. PubMed ID: 1312704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.